n Cardiovascular Journal of South Africa - Nifedipine GITS : perspectives beyond blood pressure : drug trends in cardiology
|Article Title||Nifedipine GITS : perspectives beyond blood pressure : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||May 2004|
|Pages||145 - 146|
Extracted from text ... 145 Drug Trends Nifedipine GITS: perspectives beyond blood pressure Nifedipine GITS (Adalat XL(r)), a dihydro pyridine calcium channel blocker with well-established and consistent anti-hypertensive efficacy, is now being tested for its additional vascular protective effects in the ACTION study, which examines CAD patients with angina. Prof George Noll of the University of Zurich, Switzerland, presented scientific perspectives on nifedipine's effects on endothelial function, based on accumulating experimental and clini cal data, at a recent well-attended cardio vascular symposium held in Cape Town. The pathogenesis of atherosclerosis is determined largely by endothelial function. Prof Noll stressed the pivotal role that reduced ..
Article metrics loading...